血管补片市场规模、份额及成长分析（按材料、应用和地区）—产业预测，2025 年至 2032 年

血管贴片市场规模预计在 2023 年达到 4.1867 亿美元，2024 年达到 4.5258 亿美元，到 2032 年达到 8.4393 亿美元，在预测期内（2025-2032 年）的复合年增长率为 8.10%。

慢性肾臟病(CKD) 逐渐影响肾臟功能，越来越被认为是糖尿病、高血压和心血管疾病的重要危险因子。随着 CKD 的进展，身体难以有效调节体液、电解质和废物，这可能导致危险的积聚。美国国家糖尿病、消化和肾臟疾病研究所最近的统计数据显示，美国有超过 3700 万成年人患有 CKD，凸显了对 CKD 认识和管理策略的迫切需求。这种日益增长的盛行率为医疗保健提供者和政策制定者提供了巨大的机会，使他们能够专注于预防、早期发现和创新治疗方案，以改善患者的治疗效果并减轻併发症的负担。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 重大投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究

血管补片市场规模（按材料和复合年增长率） (2025-2032)

• 市场概览
• 生物血管补片
• 合成血管补片

血管补片市场规模（依应用及复合年增长率） （2025 年至 2032 年）

• 市场概览
• 颈动脉切除术
• 腹部主动脉血管瘤开放式修补术
• 血管搭桥手术
• 先天性心臟疾病
• 其他用途

血管补片市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 门诊手术中心

血管贴片市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Baxter International Inc.（USA）
• Terumo Corporation（Japan）
• Edwards Lifesciences Corporation（USA）
• Getinge AB（Sweden）
• B. Braun SE（Germany）
• LeMaitre Vascular, Inc.（USA）
• WL Gore & Associates, Inc.（USA）
• Artivion, Inc.（formerly CryoLife, Inc.）（USA）
• Aziyo Biologics, Inc.（USA）
• Vascudyne, Inc.（USA）
• Collagen Solutions Plc（UK）
• FOC Medical SA（Switzerland）
• Obex Medical Ltd.（New Zealand）
• Vascumed（Pty）Ltd.（South Africa）
• Celox Medical（UK）
• Biom'up（France）
• Hemovent GmbH（Germany）
• Kuros Biosciences AG（Switzerland）
• Medtronic plc（Ireland）
• Abbott Laboratories（USA）

结论和建议

Vascular Patches Market size was valued at USD 418.67 Million in 2023 and is poised to grow from USD 452.58 Million in 2024 to USD 843.93 Million by 2032, growing at a CAGR of 8.10% during the forecast period (2025-2032).

Chronic kidney disease (CKD) is increasingly recognized as a significant risk factor for diabetes, hypertension, and cardiovascular diseases due to its gradual impact on kidney function. With the progression of CKD, the body struggles to regulate fluids, electrolytes, and waste effectively, which can result in dangerous buildups. Recent statistics from the National Institute of Diabetes and Digestive and Kidney Diseases reveal that more than 37 million adults in the United States are affected by CKD, highlighting the urgent need for awareness and management strategies. This growing prevalence indicates a considerable opportunity for healthcare providers and policymakers to focus on prevention, early detection, and innovative treatment solutions in order to improve patient outcomes and reduce the burden of associated comorbidities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vascular Patches market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vascular Patches Market Segments Analysis

The global Vascular Patches Market is segmented into three segments i.e. by Material, Application and Region. Based on material, the market is segmented into Biologic Vascular Patches, Synthetic Vascular Patches. Based on Application, the market is segmented into Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, Other Applications. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver of the Vascular Patches Market

The swift growth of the global elderly population is a major driver of the increasing prevalence of various health issues, including cardiovascular diseases, high cholesterol levels, hypertension, strokes, cancer, and aneurysms. Aging is a critical factor impacting cardiovascular health, and the rise in the elderly demographic significantly influences market growth in the vascular patches sector. As more individuals age, the demand for medical solutions addressing these age-related conditions surges, thereby stimulating advancements and investments in vascular patch technologies. This demographic trend underscores the urgent need for effective treatment options, further propelling the market forward.

Restraints in the Vascular Patches Market

The anticipated challenge to the growth of the Vascular Patches market during the forecast period is primarily linked to an increase in product recalls. For instance, Baxter International, a leading healthcare provider located in Illinois, recently initiated a recall of its Vascu-Guard peripheral vascular patch. Such recalls highlight prevailing quality and safety issues associated with certain medical products, which are expected to hinder the overall market's expansion. This particular incident underscores the significant effects that such events can have on market dynamics, potentially undermining consumer confidence and adversely affecting industry performance in the upcoming years.

Market Trends of the Vascular Patches Market

The vascular patches market is experiencing significant growth, driven by the rising adoption of minimally invasive procedures like MIDCAB (Minimally Invasive Direct Coronary Artery Bypass). This trend is fueled by a growing preference for safe, low-mortality interventions, alongside the compatibility of MIDCAB with cardiopulmonary bypass and aortic cross-clamping. As innovations in surgical techniques, including the use of coronary artery stent grafts, continue to evolve, they are expected to further stimulate demand for vascular grafts. Consequently, the market is poised for expansion, as healthcare providers increasingly prioritize advanced solutions that enhance patient outcomes and recovery times.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Vascular Patches Market Size by Material & CAGR (2025-2032)

• Market Overview
• Biologic Vascular Patches
• Synthetic Vascular Patches

Global Vascular Patches Market Size by Application & CAGR (2025-2032)

• Market Overview
• Carotid Endarterectomy
• Open Repair of Abdominal Aortic Aneurysm
• Vascular Bypass Surgery
• Congenital Heart Disease
• Other Applications

Global Vascular Patches Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Global Vascular Patches Market Size & CAGR (2025-2032)

• North America (Material, Application, End User)
  • US
  • Canada
• Europe (Material, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc. (formerly CryoLife, Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aziyo Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascudyne, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collagen Solutions Plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FOC Medical S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Obex Medical Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascumed (Pty) Ltd. (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celox Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biom'up (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemovent GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations